Defining a role for biopharmaceutical companies in mobile health care

Mobile healthcare or "mHealth" is a term given to represent a broad spectrum of products and services, from wearable glucose monitors, to web-based fitness applications, to networks of dispersed health care professionals developing and executing daily treatment plans for chronically ill patients.

Early reports have suggested that mHealth products and services can help provide high-quality care and a reduction in costs, particularly when managing chronic diseases.

A new paper delivered by Accenture looks at whether pharmacutical companies should make significant investments in mHealth and what solutions would prove critical and necessary when improving patient health and looking to create new value streams for key stakeholders.

Download the paper here.

Latest posts

Mobile healthcare or "mHealth" is a term given to represent a broad spectrum of products and services, from wearable glucose monitors, to web-based fitness applications, to networks of dispersed health care profe
Since 2009, The Boston Consulting Group has been studying disease registries as a potential model for value-based health care, an approach to controlling health care costs that emphasizes maximising value, define
Deloitte has produced a report that looks into how mobile technology is transforming healthcare.

The Healthcare Sector

New touch points have transformed the ways in which professionals and patients access information and manage health conditions.
Online communication, new forms of face-face education and mobile devices are redefining access to healthcare. Digital collaboration do not only allow us to offer quality content, customised for specific audiences, but also to do so in the most cost-effective way.